Ascendis Pharma A/S (ASND)
224.11
-13.36
(-5.63%)
USD |
NASDAQ |
May 29, 16:00
224.05
-0.06
(-0.03%)
After-Hours: 20:00
Ascendis Pharma EPS Diluted (Quarterly) : 11.41 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Evaxion AS | -0.4366 |
| DBV Technologies SA | -0.5577 |
| Genmab A/S | 0.0833 |
| Cellectis SA | -0.1774 |
| Akari Therapeutics Plc | -9.584 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 736.28M |
| Revenue (Quarterly) | 288.51M |
| Total Expenses (Quarterly) | -447.78M |
| Enterprise Value | 14.22B |
| Gross Profit Margin (Quarterly) | 91.37% |
| Earnings Yield | 3.96% |
| Normalized Earnings Yield | 3.959 |